• Sectors we work in banner(2)

    Quick Reads

The ongoing fight against fakes

When counterfeit goods are mentioned, initial thoughts may be of luxury items such as handbags copied in a far cheaper and more accessible form. Hidden behind such goods is the harm done to rights holders, who have invested time and money developing and producing a product, and the organised crime and downstream harm caused by such counterfeit items. However, other products are also counterfeited and the impact to the consumer can be more immediate and dangerous – electrical goods and pharmaceuticals are two categories that are also frequently copied.

EUROPOL recently coordinated the fourth edition of Operation SHIELD, a global effort to tackle fake pharmaceuticals.  The operation saw 1,284 individuals charged and took fake medicines worth EUR 64 million off EU markets.

The sale of fake pharmaceuticals, and illegal trafficking of pharmaceuticals, continues to be a growing issue and is a significant public health problem.

The Internet remains an enticing outlet for suppliers of counterfeit goods and social media is a current popular forum for selling counterfeit and illegally sold medicines. Of key importance is educating users of social media, particularly younger generations, on the significant safety risks associated with sourcing pharmaceuticals outside the legitimate supply chain. As consumers, it is key that we question what the item is and where it has come from.

Brand owners should seek to protect and enforce their trade mark rights to help curb the proliferation of counterfeit products worldwide and protect consumers. 

The EUROPOL press release makes for impressive reading but the fight against counterfeiters is ongoing. Vigilance by consumers and brand owners, and protection of important intellectual property, are key.

 

Medicines are often counterfeited in underground laboratories without any regulation or safety measures in place. Counterfeit products created under such circumstances do not produce the desired effect; in the best case scenario the patient remains untreated, however such products can cause serious health issues or be potentially lethal.

Our thinking

  • Seminar: National Association of Independent Administrators

    Events

  • In-House Insights: Building and Contributing to high performing In-House Legal Teams

    Megan Paul

    Events

  • City AM quotes Charlotte Duly on the long-awaited SkyKick v Sky Supreme Court decision

    Charlotte Duly

    In the Press

  • Charlotte Duly writes for World Intellectual Property Review on the Bluebird trademark dispute

    Charlotte Duly

    In the Press

  • Law.com International interviews Robert Reymond on the growth of our Latin America desk

    Robert Reymond

    In the Press

  • Autumn Budget 2024 – Charities – points you might have missed

    Liz Gifford

    Insights

  • Internationally competitive? The post-April 2025 tax rules for non-doms

    Dominic Lawrance

    Insights

  • Global Investigations Review quotes Rhys Novak on the UK government’s new guidance on complying with its forthcoming failure to prevent fraud offence

    Rhys Novak

    In the Press

  • Under my umbr-ETA, ESTA, eh eh… FAO: international visitors to UK from 8 January 2025 – avoid rain and flight anxiety

    Paul McCarthy

    Quick Reads

  • National Infrastructure Commission’s Report on Cost Drivers of Major Infrastructure Projects in the UK

    Charlotte Marsh

    Insights

  • Global Legal Post quotes James Walton on the CJC's interim report into litigation funding

    James Walton

    In the Press

  • Passing on family wealth – the Family Law impact of the new inheritance tax changes

    Sarah Jane Boon

    Insights

  • Potential parental disputes about school fees now VAT is to be added

    Sarah Jane Boon

    Insights

  • The new guidance on the offence of failing to prevent fraud – will it lead to a sea-change to anti-fraud compliance mechanisms?

    Rhys Novak

    Quick Reads

  • What constitutes “possession” and its importance (and relevance) for correctly calculating your SDLT liability

    Pippa Clifford

    Insights

  • Building Safety for Higher Risk Buildings – How is the Regulatory Regime bedding in?

    Kate Knox

    Insights

  • Navigating the Digital Services Act and Online Safety Act: A Quick Guide for Digital Platform Providers on the need to police content

    Dillon Ravikumar

    Quick Reads

  • Retail Collection – Episode 1: URBN

    Ilona Bateson

    Podcasts

  • The Halloween Budget – will wealth creators be spooked?

    Dominic Lawrance

    Insights

  • Transatlantic shockwaves herald sea change in UK tax treatment of US-connected individuals

    Sangna Chauhan

    Insights

Back to top